Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial.

Saved in:
Bibliographic Details
Title: Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial.
Authors: Gimsing P; Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Hjertner Ø; Department of Hematology, St. Olavs University Hospital, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Abildgaard N; Department of Hematology, Odense University Hospital, University of Southern Denmark, Odense, Denmark., Andersen NF; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Dahl TG; Department of Hematology, Rikshospitalet, Oslo, Norway., Gregersen H; Department of Hematology, Aalborg University Hospital, Denmark., Klausen TW; Department of Hematology, Herlev University Hospital, Herlev, Denmark., Mellqvist UH; Department of Hematology, Sahlgrenska University Hospital, Gothenborg, Sweden., Linder O; Department of Hematology, Örebro University Hospital, Örebro, Sweden., Lindås R; Department of Hematology, Haukeland University Hospital, Bergen, Norway., Tøffner Clausen N; Department of Hematology, Herlev University Hospital, Herlev, Denmark., Lenhoff S; Department of Hematology, Skåne University Hospital, Lund, Sweden.
Source: Bone marrow transplantation [Bone Marrow Transplant] 2015 Oct; Vol. 50 (10), pp. 1306-11. Date of Electronic Publication: 2015 Jun 29.
Publication Type: Clinical Trial, Phase II; Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5365
DOI:10.1038/bmt.2015.125